AKT1 and metabolic disease: Feedback inhibition of AKT signaling was known to limit the growth of tumors, hinting at the proper balancing of PI3K-AKT by S6K in cells under normal physiology, which when disturbed has serious implications in metabolic diseases and tumorigenesis [4, 52-54].